Araque A, Castillo PE, Manzoni OJ, Tonini R (2017) Synaptic functions of endocannabinoid signaling in health and disease. Neuropharmacology 124:13–24. https://doi.org/10.1016/j.neuropharm.2017.06.017
Article CAS PubMed PubMed Central Google Scholar
Augustin SM, Lovinger DM (2018) Functional relevance of endocannabinoid-dependent synaptic plasticity in the central nervous system. ACS Chem Neurosci 9:2146–2161. https://doi.org/10.1021/acschemneuro.7b00508
Article CAS PubMed Google Scholar
Bao H, Li H, Jia Y et al (2021) Ganoderic acid A exerted antidepressant-like action through FXR modulated NLRP3 inflammasome and synaptic activity. Biochem Pharmacol 188:114561. https://doi.org/10.1016/j.bcp.2021.114561
Article CAS PubMed Google Scholar
Basselin M, Ramadan E, Rapoport SI (2012) Imaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans. Brain Res Bull 87:154–171. https://doi.org/10.1016/j.brainresbull.2011.12.001
Article CAS PubMed Google Scholar
Bot M, Milaneschi Y, Al-Shehri T et al (2020) Metabolomics profile in depression: a pooled analysis of 230 metabolic markers in 5283 cases with depression and 10,145 controls. Biol Psychiatry 87:409–418. https://doi.org/10.1016/j.biopsych.2019.08.016
Article CAS PubMed Google Scholar
Brunt TM, Bossong MG (2022) The neuropharmacology of cannabinoid receptor ligands in central signaling pathways. Eur J Neurosci 55:909–921. https://doi.org/10.1111/ejn.14982
Article CAS PubMed Google Scholar
Calder PC (2017) Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochem Soc Trans 45:1105–1115. https://doi.org/10.1042/BST20160474
Article CAS PubMed Google Scholar
Cao S, Anishkin A, Zinkevich NS et al (2018) Transient receptor potential vanilloid 4 (TRPV4) activation by arachidonic acid requires protein kinase A-mediated phosphorylation. J Biol Chem 293:5307–5322. https://doi.org/10.1074/jbc.M117.811075
Article CAS PubMed PubMed Central Google Scholar
Caspani G, Kennedy S, Foster JA, Swann J (2019) Gut microbial metabolites in depression: understanding the biochemical mechanisms. Microb Cell 6:454–481. https://doi.org/10.15698/mic2019.10.693
Article CAS PubMed PubMed Central Google Scholar
Chahl LA (2011) TRP channels and psychiatric disorders. In: Islam MS (ed) Transient receptor potential channels. Springer Netherlands, Dordrecht, pp 987–1009
Freitas HR, Isaac AR, Malcher-Lopes R et al (2018) Polyunsaturated fatty acids and endocannabinoids in health and disease. Nutr Neurosci 21:695–714. https://doi.org/10.1080/1028415X.2017.1347373
Article CAS PubMed Google Scholar
Gai Z, Visentin M, Gui T et al (2018) Effects of farnesoid X receptor activation on arachidonic acid metabolism, NF-kB signaling, and hepatic inflammation. Mol Pharmacol 94:802–811. https://doi.org/10.1124/mol.117.111047
Article CAS PubMed Google Scholar
GBD 2015 Disease and Injury Incidence and Prevalence Collaborators (2016) Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet 388:1545–1602. https://doi.org/10.1016/S0140-6736(16)31678-6
Gopaldas M, Zanderigo F, Zhan S et al (2019) Brain serotonin transporter binding, plasma arachidonic acid and depression severity: a positron emission tomography study of major depression. J Affect Disord 257:495–503. https://doi.org/10.1016/j.jad.2019.07.035
Article CAS PubMed PubMed Central Google Scholar
Gui S, Liu Y, Zhong X et al (2018) Plasma disturbance of phospholipid metabolism in major depressive disorder by integration of proteomics and metabolomics. Neuropsychiatr Dis Treat 14:1451–1461. https://doi.org/10.2147/NDT.S164134
Article CAS PubMed PubMed Central Google Scholar
Hanna VS, Hafez EAA (2018) Synopsis of arachidonic acid metabolism: a review. J Adv Res 11:23–32. https://doi.org/10.1016/j.jare.2018.03.005
Article CAS PubMed PubMed Central Google Scholar
Hussain G, Anwar H, Rasul A et al (2020) Lipids as biomarkers of brain disorders. Crit Rev Food Sci Nutr 60:351–374. https://doi.org/10.1080/10408398.2018.1529653
Article CAS PubMed Google Scholar
Layé S, Nadjar A, Joffre C, Bazinet RP (2018) Anti-inflammatory effects of Omega-3 fatty acids in the brain: physiological mechanisms and relevance to pharmacology. Pharmacol Rev 70:12–38. https://doi.org/10.1124/pr.117.014092
Article CAS PubMed Google Scholar
Liu X, Liu C, Tian J et al (2020) Plasma metabolomics of depressed patients and treatment with Xiaoyaosan based on mass spectrometry technique. J Ethnopharmacol 246:112219. https://doi.org/10.1016/j.jep.2019.112219
Article CAS PubMed Google Scholar
Lu S, Han Y, Chu H et al (2017) Characterizing serum metabolic alterations of Alzheimer’s disease and intervention of Shengmai-San by ultra-performance liquid chromatography/electrospray ionization quadruple time-of-flight mass spectrometry. Food Funct 8:1660–1671. https://doi.org/10.1039/c7fo00154a
Article CAS PubMed Google Scholar
Malhi GS, Mann JJ (2018) Depression. Lancet 392:2299–2312. https://doi.org/10.1016/S0140-6736(18)31948-2
Mocking RJT, Naviaux JC, Li K et al (2021) Metabolic features of recurrent major depressive disorder in remission, and the risk of future recurrence. Transl Psychiatry 11:37. https://doi.org/10.1038/s41398-020-01182-w
Article CAS PubMed PubMed Central Google Scholar
Muller C, Morales P, Reggio PH (2018) Cannabinoid ligands targeting TRP channels. Front Mol Neurosci 11:487. https://doi.org/10.3389/fnmol.2018.00487
Article CAS PubMed Google Scholar
Murrough JW, Abdallah CG, Mathew SJ (2017) Targeting glutamate signalling in depression: progress and prospects. Nat Rev Drug Discov 16:472–486. https://doi.org/10.1038/nrd.2017.16
Article CAS PubMed Google Scholar
Nedic Erjavec G, Sagud M, Nikolac Perkovic M et al (2021) Depression: biological markers and treatment. Prog Neuropsychopharmacol Biol Psychiatry 105:110139. https://doi.org/10.1016/j.pnpbp.2020.110139
Article CAS PubMed Google Scholar
Pan J, Xia J, Deng F et al (2018) Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study. Transl Psychiatry 8:130. https://doi.org/10.1038/s41398-018-0183-x
Article CAS PubMed PubMed Central Google Scholar
Poleszak E, Wośko S, Sławińska K et al (2018) Cannabinoids in depressive disorders. Life Sci 213:18–24. https://doi.org/10.1016/j.lfs.2018.09.058
Article CAS PubMed Google Scholar
Pu J, Liu Y, Zhang H et al (2021) An integrated meta-analysis of peripheral blood metabolites and biological functions in major depressive disorder. Mol Psychiatry 26:4265–4276. https://doi.org/10.1038/s41380-020-0645-4
Article CAS PubMed Google Scholar
Regulska M, Szuster-Głuszczak M, Trojan E et al (2021) The emerging role of the Double-Edged impact of arachidonic Acid- derived eicosanoids in the neuroinflammatory background of depression. Curr Neuropharmacol 19:278–293. https://doi.org/10.2174/1570159X18666200807144530
Comments (0)